NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: QUESTLAB · data 2026-10-30

Quest Laboratories Ltd.

₹82-3.42% on 30 OctHealth: Strong 7.3/10
Jan 2026Low ₹74.1 · High ₹151.65-17.1%

In plain words

Price: 46.3% below its 52-week high of ₹152.6.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹82
Market cap
₹139 cr
P/E
9
P/B
1.4
ROE
16.7%
ROCE
19.3%
Debt / equity
0.08
Dividend yield
0.00%
1-year return
-6.8%
52-week high
₹152.6
52-week low
₹68.6
Operating margin
15.6%

Growth

Revenue (last 12 months)₹112 cr
Net profit (last 12 months)₹15 cr
Sales growth, 3 years (yearly)22.0%
Profit growth, 3 years (yearly)43.4%

Smart-money activity

12/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-09-30: Bulk deal: YASHVI HITESH PATEL bought ₹0.99 cr

● Deal

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Quest Laboratories Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.08, which is very low.

What is Quest Laboratories Ltd.'s P/E ratio?

About 9, based on the last 12 months' earnings and a price of ₹82 (data 2026-10-30).

What is the 52-week high and low of Quest Laboratories Ltd.?

The 52-week high is ₹152.6 and the 52-week low is ₹68.6.

Similar companies

Medico Remedies Ltd. (MEDICO) · Curis Lifesciences Limited (CURIS) · Bal Pharma Limited (BALPHARMA) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Parnax Lab Limited (PARNAXLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open QUESTLAB in NSE Scanner →
Share on WhatsAppShare on Telegram